Lupin opens R&D facility in Florida to develop inhalation products in US

Written by Meghna A Singhania Published On 2015-08-08T12:43:19+05:30 | Updated On 8 Aug 2015 12:43 PM IST

NEW DELHI: Drug major Lupin today said it has opened a research and development centre for inhalation products in Florida, the US.

The facility at Coral Springs, Florida, will focus on the research and development of inhalation products for the treatment of asthma, allergic rhinitis, chronic obstructive pulmonary diseases and other lung diseases.

"With the talent and resources this state provides, our Coral Springs expansion will further strengthen our ability to bring quality, affordable pharmaceuticals to patients in the United States and other key markets globally," Lupin CEO Vinita Gupta said in a statement.

Meghna A Singhania

Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She is a member of the Association of Healthcare Journalists. She can be contacted at meghna@medicaldialogues.in. Contact no. 011-43720751